Strains of "Achromobacter groups B and E" were examined for cellular fatty acid (CFA) composition to evaluate their chemical relatedness to known bacterial species and groups. The CFAs were liberated from whole cells by base hydrolysis, methylated, and analyzed by capillary gas-liquid chromatography. The CFA profiles of the two groups were identical and were distinct from CFA profiles of all other bacteria we have previously tested. These data provide support for results from whole-cell protein pattern analysis and DNA-DNA and rRNA-DNA hybridization studies, which show that "Achromobacter groups B and E" are biotypes of a single new genus and species.
In the past, the genus Achromobacter was regarded as comprising gram-negative rod-shaped, peritrichously flagellated bacteria, which were oxidase positive, were strictly aerobic, attacked carbohydrates oxidatively, and failed to produce 3-ketolactonate (12) . Two biotypes ofAchromobacter xylosoxidans and two of Achromobacter species conformed to this definition (12) . Strains of the latter two biotypes (also designated groups Vd-1 and Vd-2) were recovered from various clinical sources, but their significance was undetermined.
Subsequently, biochemical tests were performed on a set of Achromobacter-like strains, mostly from blood cultures. A cluster analysis was performed on the results, and six groups, A to F, were recognized (5). In further studies, groups A, C, and D proved to be not closely related to A. xylosoxidans but to represent biotypes within a single new genus and species for which the name Ochrobactrum anthropi was proposed; the new species included organisms previously referred to as Achromobacter species biotypes 1 and 2 or as groups Vd-1 and Vd-2 (8) . Subsequent studies of groups B and E, including DNA-DNA and rRNA-DNA hybridizations, together with comparisons of their wholecell protein patterns, showed that they constitute biotypes of a single new genus and species (3) . From their protein patterns, a number of subtypes could be recognized, and these were reflected in DNA restriction endonuclease digest and rRNA gene probe patterns (4) . Pending the proposal of a formal name for these organisms, we shall refer to them as "Achromobacter groups B and E."
The characteristics of "Achromobacter groups B and E" and of 0. anthropi are given elsewhere (7); the former differs from the latter in producing 0-galactosidase, in hydrolyzing esculin, and in failing to produce acid from adonitol and dulcitol; strains of "Achromobacter group B" differ from those of "group E" in producing acid from ethanol and mannitol, in reducing nitrite, and in failing to hydrolyze arginine. Since some laboratories do not include these biochemical tests in their identification scheme (2), cellular fatty acid (CFA) analysis was done to determine whether this * Corresponding author.
technique was useful for differentiation of "Achromobacter groups B and E" from 0. anthropi.
Cells for fatty acid analysis were grown for 24 h at 35°C on plates of heart infusion agar supplemented with 5% rabbit blood. The cells were harvested, saponified, and processed for total CFAs as described previously (11) . The resulting samples of fatty acid methyl esters were analyzed by capillary gas-liquid chromatography. The identification of all acids and the location of the double bond position of monounsaturated acids were accomplished by combined gas-liquid chromatography-mass spectrometry (10) .
The CFA compositions of "Achromobacter groups B and E" were essentially identical ( Table 1 ). The CFA profiles were characterized by major amounts of cis-vaccenic acid (18:1w7c) and small amounts of palmitoleic (16:1w7c), 3-hydroxymyristic (3-OH-14:0), and 3-hydroxystearic (3-OH-18:0) acids, plus moderate amounts of palmitic (16:0), margaric (17:0), stearic (18:0), and 11-methyloctadec-12-enoic (Br-19:1) acids. The presence and relative amounts of these acids were unique for "Achromobacter groups B and E" and thus provided a ready means for distinguishing them from closely related organisms. 0. anthropi, for example, contained large amounts (25%) of lactobacillic acid (19:0 cyc), which was completely absent in "Achromobacter groups B and E." Other, smaller differences listed in Table 1 (i.e., 3-OH-14:0, 2-OH-18:1, 2-OH-19:0 cyc, and Br-19:1) were consistent and very reproducible upon regrowth and retesting of each strain. The presence of moderate amounts (7 to 8%) of Br-19:1 in "Achromobacter groups B and E" was noteworthy as this acid is relatively uncommon in bacteria and has been found in amounts of 10% or greater only in strains of the genusAfipia (1).
Although little is known of the possible clinical significance of "Achromobacter groups B and E," most strains have been grown from blood cultures. One case of replacement valve endocarditis (9) and two of septicemia (6), all due to "Achromobacter group B," have been published. All strains so far reported have been from the United Kingdom. Since 1985, all isolates identified as Vd (Achromobacter sp.) with the biochemical identification scheme (2) at the Centers J. CLIN. MICROBIOL. the characteristic CFA profile of "Achromobacter groups B and E" as described in this report. CFA studies to determine whether any of the isolates identified by biochemical tests as Vd (Achromobacter sp.) before 1985 at the Centers for Disease Control are indeed "Achromobacter groups B and E" are in progress.
